Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.23.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Preferred Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Non-Controlling Interest
Beginning balance, common (in shares) at Mar. 31, 2020 [1]   87,147,023            
Beginning balance at Mar. 31, 2020 [1] $ 77,454 $ 10 $ 100 $ (71) $ 360,224 $ (591) $ (282,218) $ 0
Beginning balance, preferred (in shares) at Mar. 31, 2020 [1]     100,000          
Beginning balance, treasury (in shares) at Mar. 31, 2020 [1]       758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) [1] 54,884 [2]           54,884  
Foreign currency translation [1] (312) [2]         (312)    
Stock-based compensation expense [1] 5,877       5,877      
Shares issued:                
Exercise of stock options (in shares) [1]   2,506,383            
Exercise of stock options and warrants [1] 7,209       7,209      
Issuance of restricted shares and vesting of restricted units (in shares) [1]   136,680            
Shares for acquisition of Fyber [1] 356,686              
Ending balance, common (in shares) at Mar. 31, 2021 [1]   89,790,086            
Ending balance at Mar. 31, 2021 [1] 145,112 $ 10 $ 100 $ (71) 373,310 (903) (227,334) 0
Ending balance, preferred (in shares) at Mar. 31, 2021 [1]     100,000          
Ending balance, treasury (in shares) at Mar. 31, 2021 [1]       758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) [1] 35,569 [2]           35,546 23
Foreign currency translation [1] (39,395) [2]         (38,438)   (957)
Stock-based compensation expense [1] 19,970       19,970      
Shares issued:                
Exercise of stock options (in shares) [1]   1,311,098            
Exercise of stock options and warrants [1] 4,300       4,300      
Issuance of restricted shares and vesting of restricted units (in shares) [1]   287,218            
Shares for acquisition of Fyber (in shares) [1]   5,775,299            
Shares for acquisition of Fyber [1]         356,686      
Acquisition of non-controlling interests in Fyber [1] 2,578             2,578
Payment of withholding taxes related to the net share settlement of equity awards [1] $ (8,605)       (8,605)      
Ending balance, common (in shares) at Mar. 31, 2022 97,163,701 97,163,701 [1]            
Ending balance at Mar. 31, 2022 [1] $ 516,215 $ 10 $ 100 $ (71) 745,661 (39,341) (191,788) 1,644
Ending balance, preferred (in shares) at Mar. 31, 2022 100,000   100,000 [1]          
Ending balance, treasury (in shares) at Mar. 31, 2022 758,125     758,125 [1]        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) [1] $ 16,870 [2]           16,673 197
Foreign currency translation [1] (2,386) [2]         (2,604)   218
Stock-based compensation expense [1] $ 31,245       31,245      
Shares issued:                
Exercise of stock options (in shares) 1,248,497 966,536 [1]            
Exercise of stock options and warrants [1] $ 2,020       2,020      
Issuance of restricted shares and vesting of restricted units (in shares) [1]   122,150            
Shares for acquisition of Fyber (in shares) [1]   1,205,982            
Shares for acquisition of Fyber [1] 50,000       50,000      
Payment of withholding taxes related to the net share settlement of equity awards [1] $ (6,709)       (6,709)      
Ending balance, common (in shares) at Mar. 31, 2023 99,458,369 99,458,369 [1]            
Ending balance at Mar. 31, 2023 [1] $ 607,255 $ 10 $ 100 $ (71) $ 822,217 $ (41,945) $ (175,115) $ 2,059
Ending balance, preferred (in shares) at Mar. 31, 2023 100,000   100,000 [1]          
Ending balance, treasury (in shares) at Mar. 31, 2023 758,125     758,125 [1]        
[1] In the fiscal quarter ended June 30, 2021, the Company initiated two significant acquisitions. Please refer to Note 3—Acquisitions in the accompanying consolidated financial statements.
[2] In the fiscal quarter ended June 30, 2021, the Company initiated two significant acquisitions. Please refer to Note 3—Acquisitions, in the accompanying consolidated financial statements.